Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
March 06, 2024 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference
February 26, 2024 08:00 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update
February 22, 2024 08:00 ET
|
Cardiff Oncology, Inc.
- Management will hold a conference call on Thursday, February 29 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage...